APA

Rodby R. A., Chiou C. F., Borenstein J., Smitten A., Sengupta N., Palmer A. J., Roze S., Annemans L., Simon T. A., Chen R. S. & Lewis E. J. (20031125). The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy. : Clinical therapeutics.

Chicago

Rodby Roger A, Chiou Chion Fang, Borenstein Jeff, Smitten Allison, Sengupta Nishan, Palmer Andrew J, Roze Stéphane, Annemans Lieven, Simon Teresa A, Chen Roland S and Lewis Edmund J. 20031125. The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy. : Clinical therapeutics.

Harvard

Rodby R. A., Chiou C. F., Borenstein J., Smitten A., Sengupta N., Palmer A. J., Roze S., Annemans L., Simon T. A., Chen R. S. and Lewis E. J. (20031125). The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy. : Clinical therapeutics.

MLA

Rodby Roger A, Chiou Chion Fang, Borenstein Jeff, Smitten Allison, Sengupta Nishan, Palmer Andrew J, Roze Stéphane, Annemans Lieven, Simon Teresa A, Chen Roland S and Lewis Edmund J. The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy. : Clinical therapeutics. 20031125.